Cargando…
A Multimodal Knowledge-Based Deep Learning Approach for MGMT Promoter Methylation Identification
Glioblastoma Multiforme (GBM) is considered one of the most aggressive malignant tumors, characterized by a tremendously low survival rate. Despite alkylating chemotherapy being typically adopted to fight this tumor, it is known that O(6)-methylguanine-DNA methyltransferase (MGMT) enzyme repair abil...
Autores principales: | Capuozzo, Salvatore, Gravina, Michela, Gatta, Gianluca, Marrone, Stefano, Sansone, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787930/ https://www.ncbi.nlm.nih.gov/pubmed/36547486 http://dx.doi.org/10.3390/jimaging8120321 |
Ejemplares similares
-
Predicting MGMT Promoter Methylation in Diffuse Gliomas Using Deep Learning with Radiomics
por: Chen, Sixuan, et al.
Publicado: (2022) -
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023) -
MRI-Based Deep Learning Tools for MGMT Promoter Methylation Detection: A Thorough Evaluation
por: Robinet, Lucas, et al.
Publicado: (2023) -
Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
por: van Nifterik, K A, et al.
Publicado: (2010) -
MGMT Promoter Methylation and Parathyroid Carcinoma
por: Storvall, Sara, et al.
Publicado: (2019)